IHM
RIGL icon

Iguana Healthcare Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Iguana Healthcare Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-15,000
Closed -$335K – 96
2016
Q2 		$335K Buy
+15,000
New +$373K 0.14% 80

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Iguana Healthcare Management's RIGL Position: Q3 2016 in Review

Iguana Healthcare Management sold out of Rigel Pharmaceuticals (RIGL) in Q3 2016, closing a stake of 15,000 shares — an estimated $335K sold.

Iguana Healthcare Management first reported a position in RIGL in Q2 2016 and held it in 1 quarter. The position peaked at $335K in Q2 2016. 121 funds tracked by Wall St. Rank hold RIGL as of Q3 2016.

  • Iguana Healthcare Management reported no remaining Rigel Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Iguana Healthcare Management sold 15,000 Rigel Pharmaceuticals shares in Q3 2016, an estimated $335K.
  • Iguana Healthcare Management first reported a position in Rigel Pharmaceuticals in Q2 2016 and held it in 1 quarter.
  • Iguana Healthcare Management's Rigel Pharmaceuticals position peaked at $335K in Q2 2016.
  • 121 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2016.

Based on Iguana Healthcare Management's 13F filing for Q3 2016, filed 14 Nov 2016.